Ro is a telehealth company. To get Zepbound from Ro, you must join the company’s Body Program. This program offers prescription weight loss drugs, coaching and ongoing support, and an insurance ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Zepbound is the latest GLP-1 receptor agonist medication to be approved for weight loss. ... Ro offers an online weight loss program that combines on-demand coaching with weight loss medications, ...

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...

Ro's Body Program is a comprehensive weight loss solution that offers personalized plans utilizing a glucagon-like peptide-1 (GLP-1) receptor agonist medications such as Ozempic, Wegovy and Zepbound.

This morning, the Danish pharmaceutical giant Novo Nordisk announced the abrupt end of its brief partnership with telehealth ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...